Lipoprotein lipase (LPL) is a central enzyme in lipoprotein metabolism and is in part responsible for adipocyte lipid accumulation. Catecholamines are known to decrease the activity of LPL in adipocytes, and we have previously demonstrated that this inhibition occurs posttranscriptionally, with a prominent inhibition of LPL translation. To better characterize the inhibition of LPL translation, 3T3-L1 cells were differentiated into adipocytes, and exposed to epinephrine. Epinephrine induced a dose-dependent decrease in LPL synthesis using [35S]methionine incorporation, with no change in LPL mRNA levels, demonstrating translational regulation of LPL in this cell line. The poly A-enriched RNA from epinephrine-treated cells was translated well in vitro, and there was no difference in the polysome profiles from control and epinephrine-treated cells, suggesting that epinephrine did not affect mRNA editing, and did not induce an inhibition of translation initiation. To obtain evidence for the presence of an inhibitory factor, a cytoplasmic extract from control, and epinephrine-treated adipocytes was human. When compared to the control cell extract, the epinephrine-treated cell extract sharply inhibited LPL translation in vitro, yet had no effect on the translation of other mRNAs. Epinephrine-treated cells had fourfold more of this inhibitor activity than control cells, and this translation inhibition was partially reversed by heat treatment. To determine what region of the LPL mRNA was involved in the translation inhibition, different LPL constructs were synthesized. The inhibitory effect of the epinephrine-treated cell extract was dependent on the presence of the first 40 nucleotides of the 3' (untranslated region UTR) (nucleotides 1599-1638), whereas deletion of the 5' UTR and other areas of the 3' UTR had no effect on translation inhibition. When a sense RNA strand corresponding to this region was added to the in vitro translation reaction, it restored translation towards normal, suggesting that the sense strand was competing for a transacting binding protein.
Introduction
Lipoprotein lipase (LPL)' is a central enzyme in lipid metabolism and is subject to regulation by many different hormones and physiologic conditions (1) . In adipocytes, LPL is increased in the fed state, and is stimulated by insulin in vitro, whereas hormones that are elevated during the fasting state, such as epinephrine and glucagon, inhibit LPL.
Although the changes in LPL activity with different physiologic states have been well described, more recent studies have suggested that the mechanism of LPL regulation is complex. Depending on the regulator or the cell type, LPL regulation may be due to changes at the mRNA level, or at numerous posttranscriptional sites (reviewed in reference 1) . For example, the addition of insulin to primary cultures of rat adipocytes led to an increase in LPL expression through an increase in LPL mRNA levels (2, 3) . However, fed rats and humans demonstrated an increase in LPL activity through posttranslational mechanisms (4, 5) .
We and others have recently described several instances of regulation of LPL translation. In response to glucose (6) , thyroid hormone (7) , and catecholamines (8) , there were large changes in LPL synthesis, using [35S] methionine pulse labeling, in spite of no changes in adipocyte LPL mRNA levels. In the case of catecholamines, there was a large and rapid decrease in LPL synthesis within 30 min of the addition of epinephrine to rat adipocytes, with no change in LPL mRNA (8) . However, the mechanism of this translational regulation has not been described.
The regulation of translation has been well characterized in other systems (9) . The iron-binding protein ferritin is regulated at the level of initiation by a transacting protein that binds to a region of secondary structure on the 5' untranslated region (UTR) of the ferritin mRNA ( [10] [11] [12] . On the other hand, other studies have implicated changes in the 3' UTR of mRNA in the regulation of translation (13) . The 3' UTR is involved in the inhibition of translation of y-interferon in Xenopus oocytes (14) , and creatine kinase in the U937 cell line (15) . Studies with ornithine decarboxylase, which is under translational control by polyamines, have demonstrated coordinated regulation of translation by both the 5' and 3' UTR's (16, 17) .
This study was intended to better characterize the translational regulation of LPL by epinephrine. As described below, we provide evidence for the interaction of a cytoplasmic factor with the 3' end of the LPL mRNA, which resulted in an inhibition of LPL translation.
Methods
Cell culture and differentiation. Mouse fibroblast 3T3-Ll cells were grown on 75-cm2 culture flask (Costar Corp., Cambridge, MA), in DME (GIBCO BRL, Rockville, MD), supplemented with 10% fetal calf serum. Cells were grown to confluence and differentiated by incubation in DME with 10% fetal calf serum containing 1 pg/ml insulin, 0.5 mM isobutylmethylxanthine, and 0.25 ,uM dexamethasone for 72 h. Cells were then maintained in DME containing 10% serum and 1 Mg/ ml insulin for 5-7 d. Medium was then changed to DME containing 10% serum.
LPL synthetic rate. LPL synthetic rate was measured in cultured cells as described previously (2) . Cells were incubated in methioninefree medium for (21) , and y-actin (22), as described previously (8) .
Preparation of cytoplasmic cell extract. A cytosolic fraction was prepared as a modification of a method previously described (23) . Control and epinephrine-treated 3T3-L1 adipocytes were homogenized in 2 vol of lysis buffer (50 mM Tris-HCl, Ph 7.4, 250 mM sucrose, 35 mM KCl, 10 mM MgCl2, 0.5 mM EDTA, 7 mM Pi-mercaptoethanol), using 10 strokes of a glass homogenizer. Homogenates were centrifuged at 10,000 g for 15 min at 40C. 5 ml of the postnuclear extract was used to prepare a high speed supernatant fraction (S-100) by centrifugation at 100,000 g for 2 h at 4°C. Solid ammonium sulfate was added to the cytosolic fraction to 60% saturation and precipitated for 1/2 h on ice. Precipitated proteins were collected by centrifugation at 6,000 g for 10 min at 0°C, redissolved and dialyzed against buffer A (20 mM TrisHCl, pH 7.4, 20 mM KCl, 7 mM /3-mercaptoethanol, 0.1 mM EDTA, and 10% glycerol). Protein concentration in the cell extract was determined with a protein assay (BioRad Laboratories, Richmond, CA), using BSA as a standard. Equal quantities of the cell extract (0.1 Mg) were used in the rabbit reticulocyte lysate.
In vitro translation. For in vitro translation, RNA transcripts from a variety of human LPL cDNA constructs were used (described below). In addition, RNA transcripts were made from the cDNA's for human hormone-sensitive lipase (HSL) (24) , human colipase (25) , and neomycin phosphotransferase (Neo) (26 Polysome profiles were obtained essentially as described previously (27) . Control 10 mM MgCl2, 20 mM dithiothreitol, 150 mg/ml cycloheximide, 100 U/ml Rnasin, and 0.5 sg/ml heparin). Gradients were centrifuged at 180,000 g for 3 h at 4°C. To demonstrate the release of all LPL mRNA into the free fraction, 1 mM EDTA was added to a control gradient. Gradients were collected in 12 1-ml fractions, and polysome profiles were recorded by reading UV absorption at 260 nm. Each fraction was precipitated and RNA was extracted. Measurement of LPL mRNA levels in each fraction was done using RT-PCR, as described previously (28) . The primers for this reaction were derived from the mouse LPL cDNA sequence, and the upstream primer was nucleotides 1158-1177, and the downstream primer was nucleotides 1369-1389 (29) . An equal volume of each fraction (containing 0.1-1.0 ng RNA) was reverse transcribed, followed by PCR for 35 cycles at 55°C. The resulting ethidium bromide-stained gel was imaged using an Imagestore 5000 scanner, and analyzed using the Gelbase/Gelblot software (Ultraviolet Products, Ltd., San Gabriel, CA).
Preparation ofconstructs. Clone B (see Fig. 6 ) is LPL35, described by Wion et al. (21) . It contained 174 nucleotides of 5' untranslated sequence, the complete coding, sequence (1428 nucleotides) and 822 nucleotides of the 1950-nucleotide 3' UTR.
The full length 3.6-kb LPL construct (see clone A in Fig. 6 ) was prepared using overlapping clones of human LPL cDNA in pGEM4Z (21), as described previously (30) . For nucleotides of coding sequence preceding codons 323 and 303, respectively. After PCR using the proofreading polymerase, the fragments was cloned into the EcoRI and BamHI sites of pGEM2. The sense RNA strand (see Fig. 7 ) was generated by PCR of the clone B, using the appropriate primers, except for the addition of T7 polymerase sequences on the upstream primer.
For expression, purified plasmid DNA was digested at a polylinker restriction site downstream of the LPL insert, and in vitro RNA transcription was carried out using the appropriate upstream promoter for viral RNA polymerase.
Results
In a previous study (8) , we determined that LPL was regulated by epinephrine at the translational level in rat adipocytes. To determine whether 3T3-L1 cells responded similarly, 3T3-L1 cells were induced to differentiate, as described in Methods, and then exposed to increasing concentrations of epinephrine (10-9 to 10'-M). After a 2-h exposure to epinephrine, cells were pulse-labeled with [35S]methionine for 30 min, followed by immunoprecipitation of LPL. As shown in Fig. 1 A, the addition of epinephrine resulted in a dose-dependent decrease in immunoprecipitable radiolabeled LPL, such that there was minimal radiolabeled LPL after exposure to 10'-M epinephrine. To determine whether the decrease in LPL synthesis was paralleled by a decrease in LPL mRNA levels, cells were treated with epinephrine, followed by RNA extraction and Northern analysis. As shown in Fig. 1 B, addition of the same concentrations of epinephrine for 2 h had no effect on LPL mRNA levels, compared to the message for y-actin. Thus, the decrease in LPL synthesis, without a comparable decrease in mRNA level, suggested translational control.
Previous studies have described the regulation of translation of ferritin due to the binding of a transacting protein to the 5' UTR, resulting in dissociation of the ferritin mRNA from polysomes (10) . To mRNA to become less associated with polysomes, and therefore less efficiently translated, we examined the distribution of LPL mRNA in polysomes of 3T3-L1 adipocytes that had been treated with epinephrine for 2 h. A postmitochondrial supernatant was prepared from control and epinephrine-treated 3T3-L1 adipocytes, as described in Methods. This fraction, which contained polysomes, monosomes, free ribosomes, as well as nonribosome-associated RNA, was layered onto a 10-50% sucrose gradient, followed by ultracentrifugation. Fractions were collected and the LPL mRNA quantitated in each fraction using RT-PCR. As shown in Fig. 2 that bound to the LPL mRNA, resulting in inhibition of translation. To determine whether such a substance was present, a cytoplasmic extract was prepared from control and epinephrinetreated cells, as described in Methods, and added to the in vitro translation system. Equal quantities (0.1 jisg of protein) of the cytosolic fractions from control and epinephrine-treated cells were added to the rabbit reticulocyte lysate system, followed by the addition of an in vitro transcribed LPL mRNA (3.6 kb), and [35S I methionine. As shown in Fig. 4 , the epinephrinetreated cell extract had a greater inhibitory effect on LPL translation, when compared to the control cell extract. These inhibitory properties were partially eliminated when the epinephrinetreated cell extract was heated to 950C for 5 min. In the absence of any cell extract, translation of LPL was slightly higher than in the presence of the control extract. To determine whether this extract had nonspecific inhibitory properties on translation, a number of controls were performed. There was no change in the translation of HSL and Neo when control and epinephrinetreated cell extract was added to the in vitro translation system (Fig. 4) . In addition, the translation of human colipase was not affected by the epinephrine cell extract (data not shown). These data demonstrated that a factor in the epinephrine-treated cell extract inhibited translation of LPL mRNA, and had no effect on the translation of other mRNA's.
Some inhibition of LPL translation was apparent when control cell extract was added to the in vitro translation system. To determine the magnitude of the inhibitory effect of the epinephdCj Figure 4 rine-treated cell extract in relation to the control extract, different amounts of cell extracts were added to the in vitro translation system. As shown in Fig. 5 , the addition of increasing amounts of cell extract resulted in increased inhibition of LPL translation. When a Dixon plot was performed with these data (Fig. 5) , the concentrations of cell extract that yielded half-maximal LPL synthetic rates were determined. These data demonstrated that the inhibitory activity in the epinephrine cell extract was fourfold higher when compared to the control cells.
To determine what region of the LPL mRNA was involved in translational regulation, a series of LPL constructs were used in the in vitro translation system, as shown in Fig. 6 A. In addition to the use of the full-length 3.6-kb LPL mRNA (construct A), other constructs contained progressive deletions of the 3' UTR, along with deletions of the 5' UTR. Of note, constructs C and D contained identical 3' UTR deletions (at nucleotide 1638), but construct D also contained a truncated 5' UTR. Constructs F and G contained a truncated LPL coding sequence, along with a truncated 5' UTR.
Each of the constructs shown in Fig. 6 A were transcribed, and added to the reticulocyte lysate system in the presence of either the control or epinephrine-treated cell extracts. As shown in Fig. 6 BA constructs A, B, C, and D all translated well, and responded similarly to the cell extracts: a greater inhibition of translation by the epinephrine-treated cell extract, when compared to the control cell extract. However, constructs E, F, and G, which contained a deletion of all of the 3' UTR, all of the 5' UTR, and some of the COOH-terminal end of the coding sequence, translated well, but were not affected by the epinephrine-treated cell extract. This lack of response to the epinephrine-treated cell extracts appeared to be due to the sequence between nucleotide 1599 and 1638 in the 3' UTR. The 5' UTR of the LPL mRNA was not involved in the response to the epinephrine-treated cell extract, since constructs C and D both responded similarly, even though construct D contained a truncated 5' UTR. The inhibition of LPL synthesis by the epinephrine-treated cell extract could be due to the production of a binding protein that bound to the 3' UTR. If so, the addition of a sense RNA strand would be expected to compete for this binding protein, and remove the translation inhibition. Thus, a sense RNA strand was transcribed and added to the epinephrine-treated cell extract before the addition of the complex to the in vitro translation system. As shown in Fig. 7 (top) , this 628-bp sense strand contained the sequences from nucleotides 1512 to 2140, which covered the last 87 nucleotides of the coding sequence, and the first 541 nucleotides of the 3' UTR. Translation in the absence of competitor RNA (Fig. 7, None) increasing amounts of competitor RNA to the in vitro translation reaction, there was a progressive increase in LPL translation; i.e., a diminished effect of the epinephrine-treated cell extract. On the other hand, the competitor RNA fragment had no effect on the control cell extract, and had no effect on the in vitro translation reaction in the absence of any cell extract. Furthermore, the addition of a similar sized sequence of irrelevant mRNA (Neo) had no effect on the epinephrine cell extract (data not shown). Thus, the sense RNA strand appeared to compete with the LPL mRNA for an inhibitory binding factor.
Discussion
Previous studies of LPL have demonstrated that regulation occurs at numerous posttranscriptional sites. Depending on the cell type or regulatory factor, changes in LPL may be due to changes in mRNA levels (2, (31) (32) (33) (34) , changes in translation (6-8, 35, 36) , or changes in posttranslational processing (4, 5, 37, 38) . Catecholamines have long been known to inhibit the activity of LPL, and this inhibition is of physiologic importance in the mobilization of adipose tissue lipid during fasting, and in response to exercise (39, 40) . In a previous study, we examined the regulation of LPL by catecholamines in primary cultures of rat adipocytes (8) . LPL synthetic rate was inhibited more than fivefold within 30 min of addition of epinephrine to the medium, with no change in LPL mRNA levels. This inhibition of LPL synthesis occurred at low concentrations of epinephrine (1 nM), but further inhibition of LPL synthesis occurred at higher concentrations. In this study, the mechanism of this translational inhibition was further examined using 3T3-LI adipocytes.
As with rat adipocytes, 3T3-L1 cells demonstrated translational regulation, as manifested by an inhibition of LPL synthesis using [35S ] methionine pulse labeling, and no change in LPL mRNA levels. A number of possible mechanisms for translational regulation were examined. Changes in mRNA structure could have occurred, perhaps due to mRNA editing (41) , which could make the mRNA untranslatable. To determine whether such changes were present, poly A-enriched RNA from control and translationally repressed (epinephrine-treated) cells were translated in vitro in reticulocyte lysates. No change in in vitro translation was observed, demonstrating that there was no loss of translatability of the LPL mRNA. Because RNA binding proteins would be lost in the process of isolation of poly Aenriched RNA, these data do not rule out the presence of a transacting RNA-binding protein.
Translation may be regulated at the level of initiation, as illustrated by the iron-binding protein ferritin ( 10) . The 5 ' UTR of the ferritin mRNA contains a stem-loop structure, which is the binding site for a protein that inhibits mRNA initiation by dissociating ferritin mRNA from polysomes. To determine whether epinephrine treatment of adipocytes resulted in a dissociation of the LPL mRNA from ribosomes, polysome profiles of LPL were analyzed from control and epinephrine-treated adipocytes. No shift in polysome profile was observed in the epinephrine-treated cells, suggesting that the inhibition of translation was not due to an inhibition of initiation.
To obtain evidence for the presence of a transacting factor that regulated translation, a cytosolic fraction was prepared from control and translationally repressed cells. When this cytosolic fraction was added to an in vitro translation system, containing the full-length human LPL mRNA (transcribed in vitro from the 3.6-kb LPL cDNA), the addition of the cytosolic fraction from the translationally repressed cells resulted in an inhibition of LPL synthesis. This cell extract was specific for LPL, and had no effect on other mRNAs. The control cytosolic fraction also inhibited translation, when compared to the addition of no cell extract, and the examination of the control and epinephrinetreated cell extracts relative translation inhibition suggested that the inhibitory factor was present in both control and epinephrine-treated cell extracts, but was about fourfold higher in the epinephrine cell fraction. This factor was likely a protein, since it was partially inhibited by heat treatment. Although it is possible that the inhibitory factor was an RNA, there is no precedent for naturally occurring regulatory RNAs in eukaryotes (9) .
To determine what region of the LPL mRNA was involved in translational regulation, a series of LPL cDNA constructs were produced, transcribed into RNA, and translated in the reticulocyte lysate system in the presence and absence of the same cytosolic fractions. Constructs with truncation of the 5' UTR translated well in vitro, and were inhibited by the addition of the epinephrine-treated cell cytosolic fraction, as long as there was some 3' UTR present. From these constructs, the first 39 nucleotides of the 3' UTR (nucleotides 1599-1638) was the region of importance for LPL translation inhibition by epinephrine. To confirm that this region was important, and to obtain evidence for the presence of a binding protein, an RNA sense strand from this region was added to the in vitro translation reaction. This sense strand prevented the translation inhibition by the epinephrine-treated cell extract, indicating competition for an inhibitory factor.
Numerous studies have demonstrated the importance of the 3' UTR in mRNA stability, and several studies have shown that the 3' UTR can control translational efficiency as well (9, 42) . The /-interferon mRNA is translated very inefficiently in Xenopus oocytes, and the inhibitory effect lies mainly with the 3' UTR, although the coding sequence of,-interferon also contributes, since the substitution of another protein's coding sequence partially overcomes the translation inhibition (14) . Creatine kinase translation is also regulated by the 3' UTR through a mechanism that does not involve translation initiation.
Studies in the U937 cell line showed that an inhibition of translation elongation or termination was due to a soluble cytoplasmic factor(s), probably a protein, that bound to a region of the 3' UTR near the termination codon (15, 43) . The 3' UTR may function to increase protein translation. Studies with ornithine decarboxylase, which is under translational control by polyamines (16) , have demonstrated coordinated regulation of translation by both the 5' and 3' UTR's. Whereas ornithine decarboxylase translation initiation is inhibited by sequences in the 5' UTR of the mRNA, the 3' UTR functions to augment, and partially negate, this inhibition of translation. In a recent study, the translation of rabbit erythroid 15-lipoxygenase (LOX) was shown to be inhibited by a 48-kD RNA-binding protein that bound to a region of 19 nucleotide tandem repeats on the 3' UTR of the LOX mRNA (44) . The mechanism by which 3' UTR protein-RNA interactions inhibit translation are not clear. In some instances, the 3' UTR has been shown to be important for mRNA initiation (13, 44) . However, since no effect on initiation was observed in these studies, some step distal to initiation, such as elongation or termination, must be involved.
In summary, regulation of LPL translation occurs in 3T3-Li cells in response to epinephrine. No structural changes in the LPL mRNA were apparent that would explain the regulation, and there was no evidence for regulation of translation initiation. Evidence for the production of a transacting protein was obtained using in vitro translation, and the loss of translational regulation occurred with the use of an LPL mRNA form that lacked the 3' UTR, and by competition for transacting binding proteins with an RNA sense strand. Together, these data suggest that a transacting protein is produced in epinephrine-treated 3T3-L1 cells, and that this protein binds to the LPL mRNA between nucleotides 1599 and 1638, resulting in a decrease in translation.
